Financials
Financial year 2025
Apotheek THYS from Houthalen-Helchteren, company number BE0425115168, closed financial year 2025 with a result of € 90,714 after tax. For that financial year Apotheek THYS recorded a gross margin of € 375,041 and equity of € 543,926. Compared with financial year 2024, the result moved from € 68,954 to € 90,714. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.
€ 543,926
▼ 3% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 90,714
▲ 32% vs 2024
Profit after tax over the fiscal year.
€ 226,603
▼ 16% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 105,940 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
2.4
▼ 0.4 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 164,848
▼ 14% vs 2024
€ 68,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 12,612
▼ 18% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 246,604
▼ 13% vs 2024
€ 36,162 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.
€ 161,138
▼ 10% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 14,091
▼ 36% vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 270,620 | € 310,074 | € 378,344 | € 375,041 | ▼ 1% |
| Profit after taxes | € 32,004 | € 43,081 | € 68,954 | € 90,714 | ▲ 32% |
| Equity | € 451,693 | € 490,198 | € 559,152 | € 543,926 | ▼ 3% |
| Total debts | € 582,372 | € 539,016 | € 493,406 | € 427,802 | ▼ 13% |
| Cash | € 198,851 | € 231,861 | € 270,047 | € 226,603 | ▼ 16% |
| Land & buildings | € 103,537 | € 83,264 | € 62,991 | € 43,100 | ▼ 32% |
| Retained profit | € 389,693 | € 428,198 | € 497,152 | € 481,926 | ▼ 3% |
| Dividend | € 20,000 | € 0 | € 0 | € 105,940 | |
| Bank debt | € 356,952 | € 317,336 | € 282,237 | € 246,604 | ▼ 13% |
| Balance sheet total | € 1,034,065 | € 1,029,214 | € 1,052,558 | € 971,728 | ▼ 8% |
| Employees (FTE) | 2.3 | 2.5 | 2.8 | 2.4 | ▼ 0.4 |
Key figures of Apotheek THYS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Apotheek THYS?
What happened at Apotheek THYS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 90,714 (▲ 32% vs 2024). Source: NBB ↗
- Kesters Pharma Invest BV became a director. NBB
- Management Annelies Thys BVBA became a director. NBB
- New establishment in Houthalen-Helchteren. KBO
- Start of the company according to the CBE. KBO
In short
From € 32,004 profit in 2022 to € 90,714 profit in 2025.
Paid € 80,573 in corporate taxes since 2022.
Best year ever: 2025, with € 90,714 profit.
On average € 156,300 of value added per employee in 2025.
A new publication or filing at Apotheek THYS? We notify you, reason included.
Follow Apotheek THYSDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of MANAGEMENT ANNELIES THYS comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Apotheek THYSBehind Apotheek THYS are Management Annelies Thys BVBA and Kesters Pharma Invest BV. The shares are held by MANAGEMENT ANNELIES THYS (100%).
Directors
According to the 2025 annual accounts
Director · represented by Annelies Thys
since 2009
Director · represented by Kevin Kesters
since 2025
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Kazernelaan 22
3530 Houthalen-Helchteren
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0425.115.168
- VAT number
- BE 0425.115.168
- Registered office
- Kazernelaan 22, 3530 Houthalen-Helchteren
- Names & denominations
- Apotheek THYS
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 30 December 1983
- Peppol
- Active · Active since 19 May 2026
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers